Blackstone and TPG-backed Hologic agrees deal for precision oncology firm Reveal Genomics
Barcelona-based Reveal Genomics develops genomic diagnostic tests to guide cancer treatment, including HER2DX for HER2-positive breast cancer. The post Blackstone and TPG-backed Hologic agrees deal for precision oncology firm Reveal Genomics appeared first on PE Hub .
We haven't written up this one. PE Hub has the full story — the link below goes straight to it.